Heparin anticoagulation.
Conti
C Richard
CR
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced; D010314:Partial Thromboplastin Time; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced
D000925:Anticoagulants; D015415:Biomarkers; D006495:Heparin, Low-Molecular-Weight